Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Novartis to shutter Zolgensma plant, resulting in 275 layoffs 

By Brian Buntz | November 11, 2022

Novartis logoThe Basel, Switzerland–based Big Pharma company has decided to consolidate the manufacturing for its gene therapy Zolgensma (onasemnogene abeparvovec-xioi). Plants dedicated to producing Zolgensma were based in Libertyville, Illinois and Durham, North Carolina. The company has announced that it will close the former plant, ultimately eliminating 275 jobs. 

Novartis anticipates that the Libertyville site will remain operational until the end of 2023. 

The company also will provide 90-day notifications to employees at the Libertyville site and offer severance packages and other benefits. 

Novartis first warned that it planned to close the plant in late October. 

Earlier this year, Novartis also announced its plan to spin off its Sandoz generic and biosimilar division.  

Sales of the gene therapy Zolgensma declined in the third quarter of this year, with its use mostly constrained to infants with spinal muscular atrophy. According to Novartis, sales of gene therapy in the third quarter of 2022 were $319 million, representing a 16% decline from the previous quarter. 

In addition to reduced demand for the gene therapy, Novartis also notes that process improvements at the North Carolina site have bolstered manufacturing output.

Demand for Zolgensma could increase in the coming years. Novartis expects annual sales to eventually reach $1.5 billion to $2 billion. For that to happen, however, the company will need to win additional regulatory approvals for the gene therapy. 

The Libertyville site closure is part of a larger pattern. The company also announced that it would eliminate about 300 jobs in Dublin by the end of 2024. 

The company announced in June that it planned to eventually lay off 8,000 employees from its workforce, which recently exceeded 100,000. 

The company is also closing a Sandoz plant in Wilson, North Carolina, that produced tablets and capsules for the North American market. 

Novartis shares have had a volatile year on the New York Stock Exchange. So far this year, its stock price has fallen 3.12% to $85.13. 

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE